Predicting risk for new-onset type 2 diabetes in Chinese people with coronary heart disease and impaired glucose tolerance
मुख्य लेखकों: | Xu, S, Scott, C, Coleman, RL, Tuomilehto, J, Holman, RR |
---|---|
स्वरूप: | Conference item |
भाषा: | English |
प्रकाशित: |
Springer Nature
2019
|
समान संसाधन
-
Predicting the risk of developing type 2 diabetes in Chinese people who have coronary heart disease and impaired glucose tolerance
द्वारा: Xu, S, और अन्य
प्रकाशित: (2021) -
Predicting heart failure events in patients with coronary heart disease and impaired glucose tolerance: insights from the Acarbose Cardiovascular Evaluation (ACE) trial
द्वारा: Wamil, M, और अन्य
प्रकाशित: (2020) -
Health utilities in Chinese patients with coronary heart disease and impaired glucose tolerance (ACE): a longitudinal analysis of a randomized, double-blind, placebo-controlled trial
द्वारा: Leal, J, और अन्य
प्रकाशित: (2022) -
Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial
द्वारा: Holman, R, और अन्य
प्रकाशित: (2017) -
Effect of valsartan on kidney outcomes in people with impaired glucose tolerance.
द्वारा: Currie, G, और अन्य
प्रकाशित: (2017)